Christopher A. Lipinski - Publications, H-index & Citations

Christopher A. Lipinski

mayo clinic

32H指数

137论文数

4.6W被引数

收录论文 32

发表时间

Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial

ECLINICALMEDICINE

IF10

2024-02-01

OAAI

Lobo, Suzana Margareth; Plantefeve, Gaetan; Nair, Girish; Cavalcante, Adilson Joaquim; Moraes, Nara Franzin de; Nunes, Estevao; Barnum, Otis; Stadnik, Claudio Marcel Berdun; Lima, Maria Patelli; Lins, Muriel; Hajjar, Ludhmila Abrahao; Lipinski, Christopher; Islam, Shaheen; Ramos, Fabiano; Simon, Tiago; Martinoti, Jean-Benoit; Guimard, Thomas; Desclaux, Arnaud; Lioger, Bertrand; Neuenschwander, Fernando Carvalho; Paolino, Bruno DeSouza; Amin, Alpesh; Acosta, Samuel Amil; Dilling, Daniel Forde; Cartagena, Edgardo; Snyder, Brian; Devaud, Edouard; Marinho, Ana Karolina Barreto Berselli; Tanni, Suzana; Beato, Patricia Medeiros Milhomem; Dewit, Stephan; Selvan, Vani; Gray, Jeffrey; Fernandez, Ricardo; Pourcher, Valerie; Maddox, Lee; Kay, Richard; Azbekyan, Anait; Chabane, Mounia; Tourette, Cendrine; Esmeraldino, Luis Everton; Dilda, Pierre J.; Lafont, Rene; Mariani, Jean; Camelo, Serge; Rabut, Sandrine; Agus, Samuel; Veillet, Stanislas; Dioh, Waly; van Maanen, Rob; Morelot-Panzini, Capucine

DIFFUSE ALVEOLAR DAMAGE COMPLICATING ELECTROCONVULSIVE THERAPY

CHEST

IF8.6

2021-10-01

PREAI

Batarseh, Rami; Lipinski, Christopher; Alastal, Amro

LIGHTS AND EMPYEMA CRITERIA FOR THE DIAGNOSIS OF PURULENT PERICARDITIS

CHEST

IF8.6

2020-10-01

PREAI

Batarseh, Rami; Lipinski, Christopher; Aljasmi, Mohammed

High throughput in vivo phenotypic screening for drug repurposing: Discovery of MLR-1023 a novel insulin sensitizer and novel Lyn kinase activator with clinical proof of concept

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2020-05-01

OAAI

Lipinski, Christopher A.; Reaume, Andrew G.

The rule of five should not impede anti-parasitic drug development

INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE

IF3.4

2017-08-01

OAAI

McKerrow, James H.; Lipinski, Christopher A.

Rule of five in 2015 and beyond: Target and ligand structural limitations, ligand chemistry structure and drug discovery project decisions 五2015年及以后的规则: 靶标和配体结构限制，配体化学结构和药物发现项目决策

ADVANCED DRUG DELIVERY REVIEWS

IF17.6

2016-06-01

367

PREAI

Lipinski, Christopher A.

Badapple: promiscuity patterns from noisy evidence Badaple: 来自嘈杂证据的滥交模式

JOURNAL OF CHEMINFORMATICS

IF5.7

2016-05-28

OAAI

Yang, Jeremy J.; Ursu, Oleg; Lipinski, Christopher A.; Sklar, Larry A.; Oprea, Tudor I.; Bologa, Cristian G.

Emergency Department Rotational Patient Assignment

ANNALS OF EMERGENCY MEDICINE

IF5

2016-02-01

PREAI

Traub, Stephen J.; Stewart, Christopher F.; Didehban, Roshanak; Bartley, Adam C.; Saghafian, Soroush; Smith, Vernon D.; Silvers, Scott M.; LeCheminant, Ryan; Lipinski, Christopher A.

Thermodynamic Proxies to Compensate for Biases in Drug Discovery Methods

PHARMACEUTICAL RESEARCH

IF4.3

2015-08-27

PREAI

Ekins, Sean; Litterman, Nadia K.; Lipinski, Christopher A.; Bunin, Barry A.

Parallel Worlds of Public and Commercial Bioactive Chemistry Data 公共和商业生物活性化学数据的平行世界

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2014-12-04

OAAI

Lipinski, Christopher A.; Litterman, Nadia K.; Southan, Christopher; Williams, Antony J.; Clark, Alex M.; Ekins, Sean

Computational Prediction and Validation of an Expert's Evaluation of Chemical Probes

JOURNAL OF CHEMICAL INFORMATION AND MODELING

IF5.3

2014-10-07

OAAI

Litterman, Nadia K.; Lipinski, Christopher A.; Bunin, Barry A.; Ekins, Sean

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 在药物发现和开发环境中估算溶解度和渗透性的实验和计算方法

ADVANCED DRUG DELIVERY REVIEWS

IF17.6

2012-12-01

1.1K

PREAI

Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.

MLR-1023 Is a Potent and Selective Allosteric Activator of Lyn Kinase In Vitro That Improves Glucose Tolerance In Vivo

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2012-07-01

PREAI

Saporito, Michael S.; Ochman, Alexander R.; Lipinski, Christopher A.; Handler, Jeffrey A.; Reaume, Andrew G.

The Lyn Kinase Activator MLR-1023 Is a Novel Insulin Receptor Potentiator that Elicits a Rapid-Onset and Durable Improvement in Glucose Homeostasis in Animal Models of Type 2 Diabetes

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2012-07-01

PREAI

Ochman, Alexander R.; Lipinski, Christopher A.; Handler, Jeffrey A.; Reaume, Andrew G.; Saporito, Michael S.

Olfactory and Gustatory Hallucinations Presenting as Partial Status Epilepticus Because of Glioblastoma Multiforme

ANNALS OF EMERGENCY MEDICINE

IF5

2010-10-01

PREAI

Capampangan, Dan J.; Hoerth, Matthew T.; Drazkowski, Joseph F.; Lipinski, Christopher A.

Structural Conservation in Band 4.1, Ezrin, Radixin, Moesin (FERM) Domains as a Guide To Identify Inhibitors of the Proline-Rich Tyrosine Kinase 2

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2009-12-17

OAAI

Meurice, Nathalie; Wang, Lei; Lipinski, Christopher A.; Yang, Zhongbo; Hulme, Christopher; Loftus, Joseph C.

A crowdsourcing evaluation of the NIH chemical probes (vol 5, pg 441, 2009)

NATURE CHEMICAL BIOLOGY

IF13.7

2009-08-01

OAAI

Oprea, Tudor I.; Bologa, Cristian G.; Boyer, Scott; Curpan, Ramona F.; Glen, Robert C.; Hopkins, Andrew L.; Lipinski, Christopher A.; Marshall, Garland R.; Martin, Yvonne C.; Ostopovici-Halip, Liliana; Rishton, Gilbert; Ursu, Oleg; Vaz, Roy J.; Waller, Chris; Waldmann, Herbert; Sklar, Larry A.

A crowdsourcing evaluation of the NIH chemical probes

NATURE CHEMICAL BIOLOGY

IF13.7

2009-06-17

110

OAAI

The Pyk2 FERM domain as a target to inhibit glioma migration

MOLECULAR CANCER THERAPEUTICS

IF5.5

2009-06-10

OAAI

Loftus, Joseph C.; Yang, Zhongbo; Tran, Nhan L.; Kloss, Jean; Viso, Carole; Berens, Michael E.; Lipinski, Christopher A.